Indian shares inched higher on Wednesday, with pharma stocks leading the rise after the country approved a COVID-19 pill, although gains were limited by year-end portfolio adjustments. India has approved Merck’s COVID-19 pill and two more vaccines for emergency use as the world’s second most populous…
Indian shares ended higher in volatile trading on Monday, helped by IT and pharmacy stocks, while RBL Bank tumbled after its top boss went on medical leave and the central bank appointed an executive to the lender’s board. The NSE Nifty 50 index ended up 0.49% at 17,086.25 and the benchmark S&P BSE Sensex…
Indian shares fell on Monday, weighed down by losses in pharmaceutical stocks, although shares of Pfizer Inc’s Indian arm jumped on positive data for the parent firm’s experimental pill against COVID-19. The blue chip NSE Nifty 50 index fell 0.30% to 17,863.05 and the benchmark S&P BSE Sensex fell 0.29%…